To display releases by year, please select a year below and click Filter.
August 30, 2024
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
View Press Release
August 29, 2024
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
View Press Release
August 21, 2024
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
View Press Release
August 13, 2024
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
View Press Release
July 31, 2024
GRAIL to Announce Second Quarter 2024 Financial Results
View Press Release
July 18, 2024
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
View Press Release
July 15, 2024
GRAIL Advances the Galleri® Registrational Clinical Trial Program
View Press Release
June 24, 2024
GRAIL to Begin Trading on the Nasdaq Stock Exchange
View Press Release
June 3, 2024
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
View Press Release
May 13, 2024
GRAIL to Host Capital Markets Day
View Press Release
Displaying 11 - 20 of 79